The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Berns A.S.

First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)

Chebotareva N.V.

First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)

Sovetnikov E.N.

First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)

Kraeva V.V.

First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)

Rodionov I.V.

First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)

Devyataykina A.S.

First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)

Moiseev S.V.

First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)

Assessment of hemostasis disorders using thromboelastography in patients with chronic glomerulonephritis and nephrotic syndrome

Authors:

Berns A.S., Chebotareva N.V., Sovetnikov E.N., Kraeva V.V., Rodionov I.V., Devyataykina A.S., Moiseev S.V.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2022;25(1): 84‑90

DOI: 10.17116/profmed20222501184

Views: 2167

Downloaded: 105

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Berns AS, Chebotareva NV, Sovetnikov EN, Kraeva VV, Rodionov IV, Devyataykina AS, Moiseev SV. Assessment of hemostasis disorders using thromboelastography in patients with chronic glomerulonephritis and nephrotic syndrome. Russian Journal of Preventive Medicine. 2022;25(1):84‑90. (In Russ.)
https://doi.org/10.17116/profmed20222501184

 
МСФ на ЯМ
Close metadata

Nephrotic syndrome (NS) is accompanied by a high risk of venous and arterial thrombotic complications due to hypercoagulation. However, routine laboratory tests have insufficient sensitivity to detect hypercoagulation; therefore, integral coagulation assessment tests seem more promising for the hemostasis disorders evaluation in patients with NS.

OBJECTIVE

To characterize hemostasis system abnormalities in patients with chronic glomerulonephritis (CGN) with NS using thromboelastography (TEG).

MATERIAL AND METHODS

Forty-nine CGN patients aged 18 years or older (mean age 37 years), including 25 (51%) females and 24 (49%) males, were included in the study. Twenty (40.8%) patients were diagnosed with NS, and 29 (59.2%) had no NS. The process of clot formation was assessed by TEG with evaluation of R, K, maximum amplitude (MA), coagulation index (CI). The results were compared with routine blood chemistry tests in NS and renal dysfunction, activated partial thromboplastin time, and prothrombin time (PTT).

RESULTS

According to TEG results, a significant decrease of coagulation initiation time (R, min), as well as its correlation with cholesterol and PTT, was observed in GCN patients with NS. In patients with NS, an increase in MA, CI, and a shortening of K time (min) were recorded versus patients without NS. TEG parameters K, MA, and CI significantly correlated with the daily proteinuria, albumin level, and glomerular filtration rate, reflecting the contribution of NS and renal dysfunction to hemostasis disorders.

CONCLUSION

According to TEG results, in CGN patients with NS, an activation of plasma and platelet steps of hemostasis is observed, as evidenced by the shortening of R and increase of MA and CI. These changes correlate with the severity of hypoalbuminemia, hypercholesterolemia, and renal dysfunction in patients with NS.

Keywords:

nephrotic syndrome
thromboelastography
clotting disorders
chronic glomerulonephritis

Authors:

Berns A.S.

First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)

Chebotareva N.V.

First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)

Sovetnikov E.N.

First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)

Kraeva V.V.

First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)

Rodionov I.V.

First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)

Devyataykina A.S.

First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)

Moiseev S.V.

First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)

Received:

10.11.2021

Accepted:

29.11.2021

List of references:

  1. Singhal R, Brimble KS. Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management. Thromb Res. 2006; 118(3):397-407.  https://doi.org/10.1016/j.thromres.2005.03.030
  2. Fahal IH, McClelland P, Hay CR, Bell GM. Arterial thrombosis in the nephrotic syndrome. Postgrad Med J. 1994;70(830):905-909.  https://doi.org/10.1136/pgmj.70.830.905
  3. Panteleev MA, Ataullakhanov FI. Blood clotting: biochemical bases. Clinical oncohematology. 2008;1(1):50-62. (In Russ.).
  4. Panteleev MA, Hemker HC. Global/integral assays in hemostasis diagnostics: Promises, successes, problems and prospects. Thrombosis Journal. 2015; 13(1):1-4.  https://doi.org/10.1186/s12959-014-0032-y
  5. Stomenskaya IS, Kostrova OYu, Struchko GYu, Timofeeva NY. Thromboelastometry is a method of laboratory diagnostics of disorders of the hemostasis system. Medical almanac. 2017;2(47):96-98. (In Russ.).
  6. Avdushkina LA, Vavilova TV, Zybina NN. The method of thromboelastography/thromboelastometry in the assessment of the hemostasis system: past and present. Reference intervals. Clinical and laboratory consultation. 2009; 5:26-33. (In Russ.).
  7. Grinevich TN. Rotational thromboelastography ROTEM as a new promising method for assessing the hemostasis system in patients with a traumatological profile. News of surgery. 2010;2(18):111-121. (In Russ.).
  8. Bulanov AYu. Thromboelastography in modern clinical practice. Atlas TAG. M.: Newdiamed; 2015. (In Russ.).
  9. Mahmoodi BK, Kate MK, Waanders F, Veeger NJ, Brouwer JL, Vogt L, Navis G, van der Meer J. High Absolute Risks and Predictors of Venous and Arterial Thromboembolic Events in Patients With Nephrotic Syndrome: Results From a Large Retrospective Cohort Study. Circulation. 2008;117(2):2 24-230.  https://doi.org/10.1161/circulationaha.107.716951
  10. Hofstra JM, Wetzels JFM. Should aspirin be used for primary prevention of thrombotic events in patients with membranous nephropathy? Kidney Int. 2016;89(5):981-983.  https://doi.org/10.1016/j.kint.2016.01.019
  11. Curry ANG, Pierce JMT. Conventional and near-patient tests of coagulation. Continuing Education in Anaesthesia, Critical Care and Pain. 2007; 7(2):45-50.  https://doi.org/10.1093/bjaceaccp/mkm002
  12. Sexton DJ, Clarkson MR, Mazur MJ, Plant WD, Eustace JA. Serum D-dimer concentrations in nephrotic syndrome track with albuminuria, not estimated glomerular filtrationrate. Am J Nephrol. 2012;36(6):554-560.  https://doi.org/10.1159/000345475
  13. Gyamlani G, Molnar MZ, Lu JL, Sumida K, Kalantar-Zadeh K, Kovesdy CP. Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome. Nephrol Dial Transplant. 2017;32(1):157-164.  https://doi.org/10.1093/ndt/gfw227
  14. Glassock RG. Prophylactic anticoagulation in nephrotic syndrome: A clinical conundrum. J Am Soc Nephrol. 2007;18(8):2221-2225. https://doi.org/10.1681/ASN.2006111300
  15. Cherng SC, Huang WS, Wang YF, Yang SP, Lin YF. The role of lung scintigraphy in the diagnosis of nephrotic syndrome with pulmonary embolism. Clin Nucl Med. 2000;25(3):167.  https://doi.org/10.1097/00003072-200003000-00001
  16. Kuhlmann U, Steurer J, Bollinger A, Pouliadis G, Briner J, Siegenthaler W. Incidence and clinical significance of thromboses and thrombo-embolic complications in nephrotic syndrome patients. Schweiz Med Wochenschr. 1981;111(27-28):1034-1040.
  17. Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, D’Agati V, Appel G. Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol. 2007;2(3):445-453.  https://doi.org/10.2215/CJN.03531006
  18. Singhal R, Brimble KS. Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management. Thromb Res. 2006; 118(3):397-407.  https://doi.org/10.1016/j.thromres.2005.03.030
  19. Roy C, Deschaintre Y, Sabbagh R, Roy D, Cardinal H, Bollée G. Ischemic stroke of possible embolic etiology associated with nephritic syndrome. Kidney Int Rep. 2017;2(5):988-994.  https://doi.org/10.1016/j.ekir.2017.04.004
  20. Lionaki S. Venous Thromboembolism in Patients with Membranous Nephropathy. Clin J Am Soc Nephrol. 2012;7(1):43-51.  https://doi.org/10.2215/CJN.04250511
  21. Hamano K, Iwano M, Akai Y, et al. Expression of glomerular plasminogen activator inhibitor type 1 in glomerulonephritis. Am J Kidney Dis. 2002; 39(4):695-705.  https://doi.org/10.1053/ajkd.2002.31986
  22. Beltrami E, Jesty J. The role of membrane patch size and flow in regulating a proteolytic feedback threshold on a membrane: possible application in blood coagulation. Mathematical Biosciences. 2001;172(1):1-13.  https://doi.org/10.1016/s0025-5564(01)00064-5
  23. Owens AP 3rd, Passam FH, Antoniak S, Marshall SM, McDaniel AL, Rudel L, Williams JC, Hubbard BK, Dutton JA, Wang J, Tobias PS, Curtiss LK, Daugherty A, Kirchhofer D, Luyendyk JP, Moriarty PM, Nagarajan S, Furie BC, Furie B, Johns DG, Temel RE, Mackman N. Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin. J Clin Invest. 2012;122(2):558-568.  https://doi.org/10.1172/JCI58969
  24. Huang MJ, Wei RB, Wang ZC, ing Y, Gao YW, Li MX, Cai GY, Chen XM. Mechanisms of hypercoagulability in nephrotic syndrome associated with membranous nephropathy as assessed by thromboelastography. Thromb Res. 2015;136(3):663-668.  https://doi.org/10.1016/j.thromres.2015.06.031

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.